Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Interest Expenses (2017 - 2025)

Historic Interest Expenses for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to -$415000.0.

  • Organogenesis Holdings' Interest Expenses fell 18811.04% to -$415000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 19995.25%. This contributed to the annual value of $1.5 million for FY2024, which is 2949.77% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Interest Expenses of -$415000.0 as of Q3 2025, which was down 18811.04% from -$669000.0 recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Interest Expenses ranged from a high of $2.5 million in Q1 2021 and a low of -$961000.0 during Q1 2025
  • Its 5-year average for Interest Expenses is $575421.1, with a median of $572000.0 in 2022.
  • Its Interest Expenses has fluctuated over the past 5 years, first surged by 177333.33% in 2023, then tumbled by 28696.5% in 2025.
  • Organogenesis Holdings' Interest Expenses (Quarter) stood at $853000.0 in 2021, then tumbled by 103.52% to -$30000.0 in 2022, then surged by 1773.33% to $502000.0 in 2023, then crashed by 112.15% to -$61000.0 in 2024, then crashed by 580.33% to -$415000.0 in 2025.
  • Its Interest Expenses stands at -$415000.0 for Q3 2025, versus -$669000.0 for Q2 2025 and -$961000.0 for Q1 2025.